2024 SCHEDULE

The registration desk will be open Wednesday, April 18 from 5:30-6:30 PM. Staff will be on hand to hand out badges and answer any questions.

THURSDAY, APRIL 18 - PHARMACOLOGY PRECONFERENCE AND GENERAL SESSIONS
7:30 AM ETBreakfast served:
8:00 AM ETATTR-CM Management Product Theater hosted by Pfizer
8:45 AM ETWelcome to Pharmacology Preconference
9:00 AM ETHypertension: Responsive versus Resistant
Cheryl Dennison Himmelfarb, PhD, RN, FAAN, FAHA, FPCNA
9:50 AM ETActivity Break
10:00 AM ETCognition and CVD: The Brain and the Heart
Brittany Butts, PhD, RN
10:50 AM ETHold What?! Cardiac Clearance for Cardiovascular Procedures
Jane Linderbaum, ARNP, CNP
11:40 PM ETLunch served
12:00 PM ETHoFH Management Product Theater hosted by Regeneron
12:45 PM ETWeight Loss: Pharmacological Interventions Round Table
Lisa Maher, DNP, ARNP, FNP-BC, FPCNA
Chiadi Ndumele, MD, PhD
Cindy Lamendola, MSN, NP
Sheila Allen, Patient Champion
1:35 PM ETAnnouncements
1:40 PM ETExhibit Hall Open and Beverage Break
2:40 PM ETWelcome to General Sessions
3:00 PM ETDiversity, Health Equity and Inclusion: National and Global Perspectives on CVD
Clyde Yancy, MD, MSc, MACC, MACP, FAHA, FHFSA, FRCP, FASPC (Hon.), FPCNA (Hon.)
3:50 PM ETSpotlight on HFpEF: Heart Failure Guidelines
Chiadi Ndumele, MD, PhD
4:35 PM ETAwards Ceremony
5:15 PM ETWelcome from Florida PCNA Chapters
5:30 PM ETOpening Reception in the Exhibit Hall with Poster Presentations
6:30 PM ETDinner & CE
Forecasting Patient Access Town Hall
Hosted by the American Society for Preventive Cardiology in conjunction with Partnership to Advance Cardiovascular Health
FRIDAY, APRIL 19 - GENERAL SESSIONS
7:30 AM ETBreakfast served
8:00 AM ETMore Than Just Weight Loss: Discover the Power of a GLP-1 RA
Product Theater hosted by Novo Nordisk
8:45 AM ETWelcome
Poster Winners Announced
9:00 AM ETSleep: An Overdue Addition to Life's Essential 8
Virend Somers, MD, PhD
9:45 AM ETManagement of Chronic Coronary Disease: 2023 Guidelines
Kristin Newby, MD, MHS, FACC, FAHA, FESC
10:30 AM ETActivity Break
10:40 AM ETArtificial Intelligence: Leveraging AI for CVD Management
Osama Dasa, MD, MPH, PhD
Eileen Handberg ​PhD, ANP-BC, FACC
Yvonne Commodore-Mensah PhD, MHS, RN, FAAN, FAHA, FPCNA
Heidi Salisbury RN, MSN, CNS-BC, ACGN
11:25 AM ETTransitions of Care (ToC) for the CVD Patient
Bailey DeBlasis, MPH, MSW, LISW-S
Emily Jones PhD, RNC-OB, FAHA, FPCNA
12:10 PM ETOral Abstract Presentations
12:45 PM ETLunch served
1:00 PM ETProduct Theater: Health Disparities in Atrial Fibrillation
Hosted by Johnson & Johnson
1:45 PM ETExhibit Hall
2:50 PMTransition to Breakout Rooms
3:00 PM ETBreak Out Sessions (pick one)
Workplace Violence: Techniques for defusing hostile scenarios
Mark Kincaid, BAEM, CHSS, CPI/NCII
Murmurs: What's the Whoosh?
Christian Lorenzo, MD
Remote Patient Monitoring in Heart Failure and Beyond
Kim Newlin, RN, CNS, ANP-C
3:50 PM ETTransition to Breakout Rooms
4:00 PM ETBreak Out Sessions (pick one)
Workplace Violence: Techniques for defusing hostile scenarios
Mark Kincaid, BAEM, CHSS, CPI/NCII
Murmurs: What's the Whoosh?
Christian Lorenzo, MD
Remote Patient Monitoring in Heart Failure and Beyond
Kim Newlin, RN, CNS, ANP-C
5:00 PM ETHypertriglyceridemia Treatment: Reducing ASCVD Risk for Secondary Prevention
CE Session supported by Amarin
SATURDAY, APRIL 20 - GENERAL SESSIONS
7:30 AM ETBreakfast
8:00 AM ETHypertrophic Cardiomyopathy Treatment
Product Theater hosted by Bristol Myers Squibb
8:45 AM ETWelcome
8:50 AM ETPrevention as Early Intervention
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, FSCCT
9:35 AM ETActivity Break
9:55 AM ETWomen's CVD and Hormonal Transitions Across the Lifespan
Priya Vellanki, MD, MS
10:40 AM ETPresidential Transition
10:50 AM ETAdvocacy in Nursing
Elizabeth Aquino, PhD, RN
11:50 AM ETClosing and Prize Drawing
12:00 PM ETMeeting Adjourns

For more information on each program topic, see the Learning Objectives.

ACCREDITATION STATEMENT

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.